QIAGEN’s QuantiFERON-TB customers to gain access to fully automated workflow solution DiaSorin to add novel content to already broad LIAISON menu, over 7,000 systems installed QIAGEN announces milestone of over 40 million QuantiFERON-TB tests since launch Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) and DiaSorin (FTSE Italy […]
Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas CARLSBAD, Calif. & SAN DIEGO–Thermo Fisher Scientific and Illumina, Inc. (NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing (NGS) platforms. The best-in-class amplicon technology is highly effective in capturing DNA and […]
Companies Target Review Aimed at Molecular Oncology and Hereditary Diseases SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a […]
SEATTLE and TOKYO — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to introduce nCounter-based diagnostic assays in Japan. Under this agreement, NanoString and Riken Genesis will collaborate to register, obtain reimbursement and […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that it has entered into a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) focused on optimizing BLI’s proprietary BeaconTMOptofluidic platform with the goal of helping to accelerate Pfizer’s monoclonal antibody (mAb) […]
The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced a collaboration to develop a novel analytical platform to improve the rapid analysis of the glycosylation profiles of biotherapeutics. This is a critical quality attribute which is important for the efficacy and safety of these molecules. The consortium brings […]
Signs Master Collaboration Agreement for Assay Development and Manufacturing of Kits Supporting Biomarker Research Programs TUCSON, Ariz. and DARMSTADT, Germany — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications today announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany, a leading science and technology company. The Master Collaboration Agreement […]
Helsinki – MediSapiens, a leading developer and provider of genomic, biomedical and healthcare data solutions, joins the recently announced 59M€ FinnGen project, that aims at improving human health through genetically profiling 500.000 Finns, and combining that with a rich set of clinical data to identify new therapeutic targets, as well as diagnostic and prognostic markers […]
NDF and PerkinElmer to collaborate on a deeper look at GNE Myopathy BEVERLY HILLS, Calif. The Neuromuscular Disease Foundation (NDF) – the world’s leading nonprofit organization focused on the rare genetic disease called GNE Myopathy (GNEM, also known as HIBM) is pleased to announce its collaboration with PerkinElmer for Whole Genome Sequencing (WGS) paired with […]
NGS platform to generate additional clinical data to build out the Skyline-Helomics D-CHIP bioinformatics platform MINNEAPOLIS — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that it is expanding into Next Generation Sequencing (“NGS”) through the licensing of an NGS platform MiSeqDx®, from Illumina. […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
